Subscribe
shutterstock_1653845269_taljat_david
Taljat David / Shutterstock.com
13 October 2020Big PharmaSarah Morgan

Novartis MS drug appeal upheld in Australia

The Federal Court of Australia has backed Novartis’ appeal against a decision revoking its patent covering a multiple sclerosis drug.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Genetics
Australian court rejects cattle genome patent appeal
12 October 2020   The Federal Court of Australia has refused to block a cattle genome patent from the US, dismissing an appeal from Meat and Livestock Australia.
Big Pharma
Novartis secures victory as MS drug patent is upheld
18 August 2020   In a win for Novartis Pharmaceuticals, the US District Court for the district of Delaware has upheld the patent on its top-selling multiple sclerosis drug Gilenya.


Editor's picks

Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

Editor's picks

Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Americas
Litigation implications of the USPTO’s terminal disclaimer proposal
29 August 2024
Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Europe
Labour govt appoints new Minister with IP oversight
9 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024

More on this story

Genetics
Australian court rejects cattle genome patent appeal
12 October 2020   The Federal Court of Australia has refused to block a cattle genome patent from the US, dismissing an appeal from Meat and Livestock Australia.
Big Pharma
Novartis secures victory as MS drug patent is upheld
18 August 2020   In a win for Novartis Pharmaceuticals, the US District Court for the district of Delaware has upheld the patent on its top-selling multiple sclerosis drug Gilenya.

More on this story

Genetics
Australian court rejects cattle genome patent appeal
12 October 2020   The Federal Court of Australia has refused to block a cattle genome patent from the US, dismissing an appeal from Meat and Livestock Australia.
Big Pharma
Novartis secures victory as MS drug patent is upheld
18 August 2020   In a win for Novartis Pharmaceuticals, the US District Court for the district of Delaware has upheld the patent on its top-selling multiple sclerosis drug Gilenya.

More features

Gilead scores win in fake HIV drug dispute
Polsinelli grows roster with ex-corporate counsel
‘Don’t rely on national case law’ at the UPC: Wouter Pors, Bird & Bird
Sandoz wins $137.2m payout for lost profits in generic launch
Sanofi signs global rights deal to develop rare cancer therapy
Unified Patent Court visualised: Cases, divisions, and classes in charts
WBD to merge with firm to create ‘powerhouse’ practice
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers